Evidence map›Paper›PMID 35636532›Full record

ArticleThe Journal of infection2022

SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV.

Denise Giannone, María Belén Vecchione, Alejandro Czernikier, María Laura Polo, Virginia Gonzalez Polo, Leonel Cruces, Yanina Ghiglione, Silvia Balinotti, BBEI working group, Yesica Longueira and 3 more

Open access · greenAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Denise GiannoneFacultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina.
María Belén VecchioneFacultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina.
Alejandro CzernikierFacultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina.
María Laura PoloFacultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina.
Virginia Gonzalez PoloFacultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina.
Leonel CrucesInstituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina.
Yanina GhiglioneFacultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina.
Silvia BalinottiSanatorio Güemes, Ciudad Autónoma de Buenos Aires, Argentina.
BBEI working group
Yesica LongueiraFacultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina.
Gabriela TurkInstituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina; Facultad de Medicina, Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Natalia LauferInstituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina; Facultad de Medicina, Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Maria Florencia QuirogaInstituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET - Universidad de Buenos Aires, Paraguay 2155 Piso 11, Buenos Aires C1121ABG, Argentina; Facultad de Medicina, Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina. Electronic address: fquiroga@fmed.uba.ar.
Instituto de Investigaciones Biomédicas en Retrovirus y Sida · ARHelios Salud · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HIV InfectionsAntibodies, NeutralizingAntibodies, ViralHumansImmunity, CellularImmunity, HumoralSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antibody responsesCellular responsesCOVID-19,SARS-CoV-2HIVHIV/SARS-CoV-2 coinfectionHumoral immunity

Identifiers

PMID35636532
PMCPMC9135637
OpenAlexW4281730444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.